SAXONOV SERGE (Chief Executive Officer) sold 0.4% of their position (5K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $122.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/16/2026ACC: 0001610717-26-000145
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2019
-5K
Net shares
Net seller
$122.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−5K
Price / share
$24.56
Trade value
$122.78K
% of position
0.4%
4/14/2026
1.17M→1.17M
Total
Net shares
−5K
Net value
-$122.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 4/14/2026 | S · Sale | −5K | $24.56 | $122.78K | 0.4% | 1.17M | 1.17M |
| Total | −5K | -$122.78K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Class A Common Stock
IndirectShares owned27.00
Class A Common Stock
IndirectShares owned213.25K
Class A Common Stock
IndirectShares owned71.64K
Total
284.92K indirect284.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 27.00 | Indirect |
| Class A Common Stock | 213.25K | Indirect |
| Class A Common Stock | 71.64K | Indirect |
| Total | 284.92K | 284.92K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported